Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Gilead Sciences is a leading US biopharmaceutical company dedicated to discovering, developing, and marketing innovative medicines. The company focuses on creating treatments for life-threatening diseases such as HIV, viral hepatitis, and cancer, with the overarching goal of improving the lives of patients around the world through its groundbreaking research and therapies.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Gilead Sciences (GILD) reported its Q2 2026 results on August 4, 2026, after market close. The company reported revenue of 7803 million USD. The reported earnings per share (EPS) was -6.75 USD, beating the analyst estimate of -7.26 USD by 7.0%. Following the release, the stock price reacted with a move of -2.58%.
Generated automatically from our data — as of 08/13/2026 Read the article →
Gilead Sciences is scheduled to report its next quarterly earnings on 10/22/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Gilead Sciences last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -6.75 USD.
Across its last 5 earnings reports, Gilead Sciences stock moved by ±3.8% on average the following day. The largest reaction was +7.5% on 02/11/2025; 3 of 5 reactions were positive.
Gilead Sciences has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.